The ‘Healthy Average’ Trap: Why Standard Targets for Vitamin D, Sleep, and Diet Can Miss You

Almost every health number you have been handed, the vitamin D dose on the bottle, the "seven hours" sleep rule, the "five a day" plate, describes a population, not you. Averages are useful for planning national policy. They become misleading the moment you treat a group summary as a personal prescription. Three recent lines of research show exactly how that gap opens, and what to do about it as someone who wants to age well on the actual evidence.

How a population average becomes your personal target

Guidelines translate messy population data into a single, memorable figure. That compression is deliberate and often reasonable. The problem is that a mean can hide enormous individual variation, and it can hide the difference between "associated with" and "caused by." When the compressed number then gets printed on a label or a wellness poster, the caveats fall away. You are left following a target that was never calibrated to a single person.

Here is the concrete cost. Imagine two 55-year-olds who both take the same 1,000 IU of vitamin D each day. One reaches a blood level of 34 ng/mL; the other, a poor absorber with more body fat and darker skin, sits at 19 ng/mL. Same dose, same "compliance," very different biology. The average of the two looks fine. Neither individual is served by the average.

Established evidence: three places the average misleads

Vitamin D: the dose was miscalculated from group means

In 2011 the U.S. Institute of Medicine set the Recommended Dietary Allowance for vitamin D at 600 IU per day, meant to bring 97.5% of adults above a blood level of 20 ng/mL (50 nmol/L). In 2014, Veugelers and Ekwaru re-examined the underlying data and reported a statistical error: the calculation had used the average response across study groups rather than individual responses. Correcting for individual variability, they estimated the intake needed to get 97.5% of people above 20 ng/mL was roughly an order of magnitude higher (published in Nutrients, 2014).

Two honest caveats. First, their headline figure required extrapolating beyond the trials' actual dosing range, and a published letter flagged exactly that limitation, so the precise number is uncertain. Second, more is not automatically better. Meta-analysis of all-cause mortality finds risk falling as blood levels rise toward roughly 30 to 36 ng/mL, then flattening; it plateaus rather than continuing to drop, and there is no reliable case for pushing far higher. The point is not "take mega-doses." It is that the standard dose was built on a group average and may leave many individuals short of even a modest target.

Sleep: the mortality number is an association, not a lever

A 2025 meta-analysis in GeroScience pooling dozens of cohorts reported that sleeping under 7 hours per night carried about a 14% higher all-cause mortality risk (hazard ratio 1.14), with long sleep of 9 hours or more carrying roughly 34% higher risk. Those are real, sizeable associations. But sleep can be a cause of illness, a consequence of it, or a symptom of it, sometimes all three at once. The population data cannot tell you which. Extrapolating from "short sleepers die sooner" to "adding an hour buys you years" treats a correlation as a proven mechanism. Reasonable is not the same as demonstrated.

Flavanols: the food group does not guarantee the compound

"Five a day" is an average-level rule that says nothing about a specific protective compound. A 2026 analysis in Food & Function, drawing on more than 30,000 adults, found that fewer than one in four people who met fruit and vegetable guidelines reached 500 mg per day of flavanols, the intake linked to cardiovascular benefit in the COSMOS cocoa-flavanol trial. Flavanols cluster in a few foods (apples, berries, tea, cocoa, beans) and are sparse elsewhere. Hitting the serving count is an average that can leave your individual flavanol intake well below the studied threshold.

Emerging evidence: measuring the individual instead of the average

The counter-move is to measure the person, not assume the group. A 2026 paper in Mechanisms of Ageing and Development described a "Blood Biochemistry Age Clock" built from 11 routinely ordered blood biomarkers, validated in the UK Biobank as a predictor of all-cause mortality and designed to be interpretable, so you can see which markers are pulling your biological age up or down. This is emerging work, not a clinical standard, and such clocks still need prospective validation before they guide treatment. But the direction is clear: individualized readouts are starting to replace one-size-fits-all cutoffs.

Personal experimentation: finding your own numbers

Treat the guideline as a starting hypothesis, then test it on yourself. A simple, low-risk protocol:

1. List the average-based targets you currently follow (a vitamin D dose, a sleep duration, a servings count).
2. Measure your actual individual value where a test exists. For vitamin D, order a serum 25-hydroxyvitamin D test rather than guessing from the dose.
3. Change one variable at a time and hold the rest steady, so you can attribute any change.
4. Re-measure after a sensible interval. Vitamin D blood levels take about 8 to 12 weeks to stabilize after a dose change.
5. Aim for the range associated with lowest risk (for vitamin D, roughly 30 to 40 ng/mL), not the highest number you can reach.

Mistakes to avoid

• The extrapolation error: dosing toward a figure derived beyond the data that produced it. The corrected vitamin D estimate is a direction, not a prescription.
• Association mistaken for causation: assuming that forcing an extra hour of sleep, or a supplement, delivers the lifespan the epidemiology hints at.
• "More is better" past the plateau: pushing vitamin D far above the range where mortality risk stops falling; benefit flattens and the safety margin narrows.
• Food group equals compound: believing "five a day" guarantees 500 mg of flavanols. It usually does not.
• One reading as destiny: treating a single blood draw or one clock output as fixed, rather than a trend to track.

What to track

Watch observable markers, not slogans: your measured serum 25-hydroxyvitamin D in ng/mL; sleep consistency and duration from a wearable or a simple log; resting heart rate and, if you train, VO2max trend; and, over years, the routine blood panel that feeds interpretable age clocks. Numbers you have measured on yourself beat numbers averaged over a crowd.

The takeaway

The averages are not wrong; they are just aimed at a population, and you are a sample size of one. This week, pick one average-based target you follow blindly, find the individual measurement behind it (a vitamin D test is the easiest place to start), and let your own data, not the crowd's, set your next move.

Written for Thrive Through Time. Educational content on longevity evidence, not medical advice; discuss testing and dosing changes with your clinician.

Sources